MWNA
VSTM icon

Marshall Wace North America’s Verastem VSTM Stock Holding History

Marshall Wace North America’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,748
Closed -$62K – 1641
2019
Q1 		$62K Buy
+1,748
New +$69.1K ﹤0.01% 1222
2018
Q3 		– Sell
-1,958
Closed -$162K – 1393
2018
Q2 		$162K Sell
1,958
-1,720
-47% -$105K ﹤0.01% 1293
2018
Q1 		$132K Sell
3,678
-19,043
-84% -$738K ﹤0.01% 1361
2017
Q4 		$837K Sell
22,721
-28,004
-55% -$1.26M ﹤0.01% 1031
2017
Q3 		$3.04M Buy
+50,725
New +$2.39M 0.02% 692

Other funds holding VSTM

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's VSTM Position: Q2 2019 in Review

Marshall Wace North America sold out of Verastem (VSTM) in Q2 2019, closing a stake of 1,748 shares — an estimated $62K sold.

Marshall Wace North America first reported a position in VSTM in Q3 2017 and held it in 5 quarters. The position peaked at $3.04M in Q3 2017. 94 funds tracked by Wall St. Rank hold VSTM as of Q2 2019.

  • Marshall Wace North America reported no remaining Verastem position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 1,748 Verastem shares in Q2 2019, an estimated $62K.
  • Marshall Wace North America first reported a position in Verastem in Q3 2017 and held it in 5 quarters.
  • Marshall Wace North America's Verastem position peaked at $3.04M in Q3 2017.
  • 94 funds tracked by Wall St. Rank held Verastem as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.